Citations for
1CBLCA, SEPSECS
Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.
Agamy O, Ben Zeev B, Lev D, Marcus B, Fine D, Su D, Narkis G, Ofir R, Hoffmann C, Leshinsky-Silver E, Flusser H, Sivan S, Söll D, Lerman-Sagie T, Birk OS.
Am J Hum Genet 87(4):538-44.PMID: 20920667 2010
2SEPSECS
Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis.
Palioura S, Herkel J, Simonović M, Lohse AW, Söll D.
Biol Chem 391(7):771-6.PMID: 20623998 2010
3SEPSECS
The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation.
Palioura S, Sherrer RL, Steitz TA, Söll D, Simonovic M.
Science 325(5938):321-5.PMID: 19608919 2009
4SEPSECS
Structural insights into RNA-dependent eukaryal and archaeal selenocysteine formation.
Araiso Y, Palioura S, Ishitani R, Sherrer RL, O'Donoghue P, Yuan J, Oshikane H, Domae N, Defranco J, Söll D, Nureki O.
Nucleic Acids Res 36(4):1187-99. Epub 2007 Dec 23.PMID: 18158303 2008
5SEPSECS
Characterization of human gene encoding SLA/LP autoantigen and its conserved homologs in mouse, fish, fly, and worm.
Wang CX, Teufel A, Cheruti U, Grštzinger J, Galle PR, Lohse AW, Herkel J.
World J Gastroenterol 12(6):902-7. 2006
6SEPSECS, TRNAU1AP
Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery.
Xu XM, Mix H, Carlson BA, Grabowski PJ, Gladyshev VN, Berry MJ, Hatfield DL.
J Biol Chem 280(50):41568-75. Epub 2005 Oct 17.PMID: 16230358 2005
7SEPSECS
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, Lohse AW.
Lancet 355(9214):1510-5. 2000
8SEPSECS
Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis.
Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C.
Clin Exp Immunol 121(2):364-74. 2000